Last reviewed · How we verify

NCT04993651

Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing CPAP in Morbid Obesity in 66 participants. Completed in 30 June 2023.

Timeline
11 October 2021
Primary endpoint
9 May 2023
30 June 2023

Quick facts

Lead sponsorEastern Virginia Medical School
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment66
Start date11 October 2021
Primary completion9 May 2023
Estimated completion30 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Virginia Medical School

Who can join

Adults 18 to 45, female only, with Morbid Obesity or Cesarean Delivery Affecting Fetus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of our study is to evaluate the effect of CPAP on umbilical cord acid base status in morbidly obese women at the time of scheduled cesarean delivery. We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CPAP

Trials testing the same drug.

Other recruiting trials for Morbid Obesity

Currently open trials in the same condition.

Other Eastern Virginia Medical School trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04993651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing